Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

The variations L181 and L175G25C4G were tested for their skin sensitising potential in GLP guideline studies according to OECD 429 (modified).

Both variations did not reveal any sensitising properties in the local lymph node assay (modified).

The same result is expected for other variations of the substance pentaaluminium triyttrium dodecaoxide.


Migrated from Short description of key information:
The variations L181 and L175G25C4G were tested for their skin sensitising potential. Both variations did not reveal any sensitising properties in the local lymph node assay (modified)

Justification for selection of skin sensitisation endpoint:
Both studies were selected.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Pentaaluminium triyttrium dodecaoxide did not show any potential to cause skin sensitisation.